T E Witzig|R A Kyle|P R Greipp - JoVE Visualize

Showing results (1-10 of 488) with videos related to

Pageof 49

Sort By:

Current Topics in Microbiology and Immunology|January 1, 1992

Circulating peripheral blood plasma cells in multiple myelomaT E Witzig, R A Kyle, P R Greipp

Cancer|July 1, 1993

Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myelomaT E Witzig, M V Dhodapkar, R A Kyle, et al.

British Journal of Haematology|June 1, 1994

Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myelomaT E Witzig, R A Kyle, W M O'Fallon, et al.

Leukemia|December 1, 1995

A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myelomaM A Gertz, J P Garton, P R Greipp, et al.

British Journal of Haematology|March 1, 1995

Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myelomaT E Witzig, M A Gertz, A A Pineda, et al.

British Journal of Haematology|March 6, 1998

Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosisE A McElroy, T E Witzig, M A Gertz, et al.

Leukemia & Lymphoma|November 1, 1995

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?T E Witzig, M A Gertz, J A Lust, et al.

British Journal of Haematology|June 1, 1995

Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?P Mathew, G J Ahmann, T E Witzig, et al.

American Journal of Hematology|November 1, 1985

Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1)P R Greipp, T E Witzig, N J Gonchoroff

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

Pageof 49

Showing results (1-10 of 488) with videos related to

Sort By:

Pageof 49

Current Topics in Microbiology and Immunology|January 1, 1992

Circulating peripheral blood plasma cells in multiple myelomaT E Witzig, R A Kyle, P R Greipp

Cancer|July 1, 1993

Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myelomaT E Witzig, M V Dhodapkar, R A Kyle, et al.

British Journal of Haematology|June 1, 1994

Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myelomaT E Witzig, R A Kyle, W M O'Fallon, et al.

Leukemia|December 1, 1995

A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myelomaM A Gertz, J P Garton, P R Greipp, et al.

British Journal of Haematology|March 1, 1995

Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myelomaT E Witzig, M A Gertz, A A Pineda, et al.

British Journal of Haematology|March 6, 1998

Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosisE A McElroy, T E Witzig, M A Gertz, et al.

Leukemia & Lymphoma|November 1, 1995

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?T E Witzig, M A Gertz, J A Lust, et al.

British Journal of Haematology|June 1, 1995

Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?P Mathew, G J Ahmann, T E Witzig, et al.

American Journal of Hematology|November 1, 1985

Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1)P R Greipp, T E Witzig, N J Gonchoroff

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999

Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.

Pageof 49